Report Overview
Report Summary
The global IVIg Powder market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the IVIg Powder market based on company, product type, end user and key regions.
This report studies the global market size of IVIg Powder in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of IVIg Powder in these regions.
This research report categorizes the global IVIg Powder market by top players/brands, region, type and end user. This report also studies the global IVIg Powder market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market size by Product
2.5g
1.25g
Market size by End User
Immunodeficiency
Autoimmune Disease
Acute Infection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global IVIg Powder market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of IVIg Powder market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global IVIg Powder companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of IVIg Powder submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of IVIg Powder are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of IVIg Powder market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 IVIg Powder Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global IVIg Powder Market Size Growth Rate by Product
1.4.2 2.5g
1.4.3 1.25g
1.5 Market by End User
1.5.1 Global IVIg Powder Market Size Growth Rate by End User
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global IVIg Powder Market Size
2.1.1 Global IVIg Powder Revenue 2017-2027
2.1.2 Global IVIg Powder Sales 2017-2027
2.2 IVIg Powder Growth Rate by Regions
2.2.1 Global IVIg Powder Sales by Regions
2.2.2 Global IVIg Powder Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 IVIg Powder Sales by Manufacturers
3.1.1 IVIg Powder Sales by Manufacturers
3.1.2 IVIg Powder Sales Market Share by Manufacturers
3.1.3 Global IVIg Powder Market Concentration Ratio (CR5 and HHI)
3.2 IVIg Powder Revenue by Manufacturers
3.2.1 IVIg Powder Revenue by Manufacturers (2017-2020)
3.2.2 IVIg Powder Revenue Share by Manufacturers (2017-2020)
3.3 IVIg Powder Price by Manufacturers
3.4 IVIg Powder Manufacturing Base Distribution, Product Types
3.4.1 IVIg Powder Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IVIg Powder Product Type
3.4.3 Date of International Manufacturers Enter into IVIg Powder Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global IVIg Powder Sales by Product
4.2 Global IVIg Powder Revenue by Product
4.3 IVIg Powder Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global IVIg Powder Breakdown Data by End User
6 North America
6.1 North America IVIg Powder by Countries
6.1.1 North America IVIg Powder Sales by Countries
6.1.2 North America IVIg Powder Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America IVIg Powder by Product
6.3 North America IVIg Powder by End User
7 Europe
7.1 Europe IVIg Powder by Countries
7.1.1 Europe IVIg Powder Sales by Countries
7.1.2 Europe IVIg Powder Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe IVIg Powder by Product
7.3 Europe IVIg Powder by End User
8 Asia Pacific
8.1 Asia Pacific IVIg Powder by Countries
8.1.1 Asia Pacific IVIg Powder Sales by Countries
8.1.2 Asia Pacific IVIg Powder Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific IVIg Powder by Product
8.3 Asia Pacific IVIg Powder by End User
9 Central & South America
9.1 Central & South America IVIg Powder by Countries
9.1.1 Central & South America IVIg Powder Sales by Countries
9.1.2 Central & South America IVIg Powder Revenue by Countries
9.1.3 Brazil
9.2 Central & South America IVIg Powder by Product
9.3 Central & South America IVIg Powder by End User
10 Middle East and Africa
10.1 Middle East and Africa IVIg Powder by Countries
10.1.1 Middle East and Africa IVIg Powder Sales by Countries
10.1.2 Middle East and Africa IVIg Powder Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa IVIg Powder by Product
10.3 Middle East and Africa IVIg Powder by End User
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Company Business Overview
11.1.3 Baxter IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Baxter IVIg Powder Products Offered
11.1.5 Baxter Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Company Business Overview
11.2.3 Grifols IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Grifols IVIg Powder Products Offered
11.2.5 Grifols Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 Company Business Overview
11.3.3 CSL IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.3.4 CSL IVIg Powder Products Offered
11.3.5 CSL Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Company Business Overview
11.4.3 Octapharma IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Octapharma IVIg Powder Products Offered
11.4.5 Octapharma Recent Development
11.5 Biotest
11.5.1 Biotest Company Details
11.5.2 Company Business Overview
11.5.3 Biotest IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Biotest IVIg Powder Products Offered
11.5.5 Biotest Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Company Business Overview
11.6.3 Kedrion IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Kedrion IVIg Powder Products Offered
11.6.5 Kedrion Recent Development
11.7 Hualan Bio
11.7.1 Hualan Bio Company Details
11.7.2 Company Business Overview
11.7.3 Hualan Bio IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Hualan Bio IVIg Powder Products Offered
11.7.5 Hualan Bio Recent Development
11.8 CNBG
11.8.1 CNBG Company Details
11.8.2 Company Business Overview
11.8.3 CNBG IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.8.4 CNBG IVIg Powder Products Offered
11.8.5 CNBG Recent Development
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Details
11.9.2 Company Business Overview
11.9.3 Shanghai RAAS IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Shanghai RAAS IVIg Powder Products Offered
11.9.5 Shanghai RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 Company Business Overview
11.10.3 CBPO IVIg Powder Sales, Revenue and Gross Margin (2017-2020)
11.10.4 CBPO IVIg Powder Products Offered
11.10.5 CBPO Recent Development
11.11 LFB Group
11.12 BPL
11.13 Sichuan Yuanda Shuyang
12 Future Forecast
12.1 IVIg Powder Market Forecast by Regions
12.1.1 Global IVIg Powder Sales Forecast by Regions 2021-2027
12.1.2 Global IVIg Powder Revenue Forecast by Regions 2021-2027
12.2 IVIg Powder Market Forecast by Product
12.2.1 Global IVIg Powder Sales Forecast by Product 2021-2027
12.2.2 Global IVIg Powder Revenue Forecast by Product 2021-2027
12.3 IVIg Powder Market Forecast by End User
12.4 North America IVIg Powder Forecast
12.5 Europe IVIg Powder Forecast
12.6 Asia Pacific IVIg Powder Forecast
12.7 Central & South America IVIg Powder Forecast
12.8 Middle East and Africa IVIg Powder Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IVIg Powder Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer